{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:16:11Z","timestamp":1762503371445,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ctro.2023.100679","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T22:52:38Z","timestamp":1694818358000},"page":"100679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hypofractionation of radiation dose to the prostate does not necessarily imply a greater risk of acute radiation proctitis"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2305-5544","authenticated-orcid":false,"given":"Gianluca","family":"Ferini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4696-7634","authenticated-orcid":false,"given":"Stefano","family":"Pergolizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"40","key":"10.1016\/j.ctro.2023.100679_b0005","article-title":"Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis","volume":"17","author":"Sinzabakira","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2023.100679_b0010","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.21873\/invivo.12390","article-title":"A ten-year-long update on radiation proctitis among prostate cancer patients treated with curative external beam radiotherapy","volume":"35","author":"Ferini","year":"2021","journal-title":"In Vivo"},{"issue":"1","key":"10.1016\/j.ctro.2023.100679_b0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.radonc.2016.07.018","article-title":"Image-guided radiotherapy for prostate cancer with cone beam CT: dosimetric effects of imaging frequency and PTV margin","volume":"121","author":"Ariyaratne","year":"2016","journal-title":"Radiother Oncol"},{"issue":"17","key":"10.1016\/j.ctro.2023.100679_b0020","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1200\/JCO.2016.71.7397","article-title":"Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer","volume":"35","author":"Catton","year":"2017","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2023.100679_b0025","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.rpor.2018.06.008","article-title":"Acute toxicity and quality of life in high risk prostate cancer patients: Updated results of randomized hypofractionation trial","volume":"23","author":"Karklelyte","year":"2018","journal-title":"Rep Pract Oncol Radiother"},{"issue":"8","key":"10.1016\/j.ctro.2023.100679_b0030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/1748-717X-8-206","article-title":"A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients","volume":"4","author":"Norkus","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2023.100679_b0035","series-title":"Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic","first-page":"435","article-title":"Early toxicity of hypofractionated radiotherapy for prostate cancer","author":"Krupa","year":"2016"},{"issue":"4","key":"10.1016\/j.ctro.2023.100679_b0040","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.prro.2017.01.003","article-title":"Acute and late toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated pelvic radiation therapy","volume":"7","author":"Faria","year":"2017","journal-title":"Pract Radiat Oncol"},{"issue":"9","key":"10.1016\/j.ctro.2023.100679_b0045","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/1748-717X-9-214","article-title":"Image guided intensity modulated hypofractionated radiotherapy in high-risk prostate cancer patients treated four or five times per week: analysis of toxicity and preliminary results","volume":"26","author":"Valeriani","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2023.100679_b0050","doi-asserted-by":"crossref","unstructured":"Cuccia F, Corradini S, Mazzola R, Spiazzi L, Rigo M, Bon\u00f9 ML, Ruggieri R, Buglione di Monale E Bastia M, Magrini SM, Alongi F. MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer. Cancers (Basel). 2021 Apr 9;13(8):1791. doi: 10.3390\/cancers13081791. PMID: 33918650; PMCID: PMC8070332.","DOI":"10.3390\/cancers13081791"},{"issue":"8","key":"10.1016\/j.ctro.2023.100679_b0055","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2023.100679_b0060","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1470-2045(14)70482-6","article-title":"Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial","volume":"16","author":"Aluwini","year":"2015","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2023.100679_b0065","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ijrobp.2018.07.2006","article-title":"Daily versus weekly prostate cancer image guided radiation therapy: phase 3 multicenter randomized trial","volume":"102","author":"de Crevoisier","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2023.100679_b0070","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/1533034614566994","article-title":"High-dose robotic stereotactic body radiotherapy in the treatment of patients with prostate cancer: preliminary results in 26 patients","volume":"15","author":"Pontoriero","year":"2016","journal-title":"Technol Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.ctro.2023.100679_b0075","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.21873\/anticanres.14981","article-title":"How much daily image-guided volumetric modulated arc therapy is useful for proctitis prevention with respect to static intensity modulated radiotherapy supported by topical medications among localized prostate cancer patients?","volume":"41","author":"Ferini","year":"2021","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.ctro.2023.100679_b0080","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3390\/gastroent12040043","article-title":"Radiation proctitis: the potential role of hyaluronic acid in the prevention and restoration of any damage to the rectal mucosa among prostate cancer patients submitted to curative external beam radiotherapy","volume":"12","author":"Ferini","year":"2021","journal-title":"Gastroenterol Insights"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630823001040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630823001040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:12:13Z","timestamp":1762503133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630823001040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":16,"alternative-id":["S2405630823001040"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2023.100679","relation":{},"ISSN":["2405-6308"],"issn-type":[{"type":"print","value":"2405-6308"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypofractionation of radiation dose to the prostate does not necessarily imply a greater risk of acute radiation proctitis","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2023.100679","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100679"}}